Skip to Main content Skip to Navigation
Journal articles

Complication-related removal of totally implantable venous access port systems: Does the interval between placement and first use and the neutropenia-inducing potential of chemotherapy regimens influence their incidence? A four-year prospective study of 4045 patients

Abstract : Background: Totally implantable venous access port systems are widely used in oncology, with frequent complications that sometimes necessitate device removal. The aim of this study is to investigate the impact of the time interval between port placement and initiation of chemotherapy and the neutropenia-inducing potential of the chemotherapy administered upon complication-related port removal. Patients and methods: Between January 2010 and December 2013, 4045 consecutive patients were included in this observational, single-center prospective study. The chemotherapy regimens were classified as having a low (<10%), intermediate (10-20%), or high (>20%) risk for inducing neutropenia. Results: The overall removal rate due to complications was 7.2%. Among them, port-related infection (2.5%) and port expulsion (1%) were the most frequent. The interval between port insertion and its first use was shown to be a predictive factor for complication-related removal rates. A cut-off of 6 days was statistically significant (p = 0.008), as the removal rate for complications was 9.4% when this interval was 0-5 days and 5.7% when it was ≥6 days. Another factor associated with port complication rate was the neutropenia-inducing potential of the chemotherapy regimens used, with removal for complications involved in 5.5% of low-risk regimens versus 9.4% for the intermediate- and high-risk regimens (p = 0.003). Conclusion: An interval of 6 days between placement and first use of the port reduces the removal rate from complications. The intermediate- and high-risk for neutropenia chemotherapy regimens are related to higher port removal rates from complications than low-risk regimens.
Document type :
Journal articles
Complete list of metadata

Cited literature [17 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02940553
Contributor : Michel Salzet <>
Submitted on : Wednesday, September 16, 2020 - 1:17:10 PM
Last modification on : Wednesday, October 14, 2020 - 4:10:08 AM
Long-term archiving on: : Thursday, December 3, 2020 - 8:09:50 AM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

A. Kakkos, L. Bresson, D. Hudry, S. Cousin, C. Lervat, et al.. Complication-related removal of totally implantable venous access port systems: Does the interval between placement and first use and the neutropenia-inducing potential of chemotherapy regimens influence their incidence? A four-year prospective study of 4045 patients. EJSO - European Journal of Surgical Oncology, WB Saunders, 2017, 43 (4), pp.689-695. ⟨10.1016/j.ejso.2016.10.020⟩. ⟨inserm-02940553⟩

Share

Metrics

Record views

27